Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine dimesylate for fatigue in multiple sclerosis
IRCT20241129063892N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lisdexamfetamine in multiple sclerosis (MS), sponsored by Mazandaran University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20241129063892N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241129063892N2.